Inventor · disambiguated record
David S. Eisenberg
Also filed as: EISENBERG DAVID · EISENBERG DAVID S
20 granted patents·6 pending applications·706 citations·filing 1994–2022
95Inventor score
Files withUNIV CALIFORNIA17EISENBERG DAVID S3BEAMER LESA J1HARVARD COLLEGE1THE REGENTS OF UNIV OF CALIFORNIA1
Top patents by PatentIndex Score
26 records- 0193US5843711ADiphtheria toxin receptor-binding regionUNIV CALIFORNIA·Filed 1995·Granted Dec 1, 1998·181 cites·15 claims
- 0292US5917017ADiphtheria toxin vaccines bearing a mutated R domainHARVARD COLLEGE·Filed 1994·Granted Jun 29, 1999·194 cites·27 claims
- 0390US7125680B2Methods and materials for characterizing and modulating interaction between heregulin and HER3UNIV CALIFORNIA·Filed 2002·Granted Oct 24, 2006·33 cites·4 claims
- 0489US6564151B1Assigning protein functions by comparative genome analysis protein phylogenetic profilesUNIV CALIFORNIA·Filed 2000·Granted May 13, 2003·23 cites·30 claims
- 0588US6466874B1Rosetta stone method for detecting protein function and protein-protein interactions from genome sequencesUNIV CALIFORNIA·Filed 2000·Granted Oct 15, 2002·20 cites·19 claims
- 0687US6892139B2Determining the functions and interactions of proteins by comparative analysisUNIV CALIFORNIA·Filed 2000·Granted May 10, 2005·31 cites·31 claims
- 0786US6093573AThree-dimensional structure of bactericidal/permeability-increasing protein (BPI)XOMA·Filed 1997·Granted Jul 25, 2000·82 cites·6 claims
- 0886US5436850AMethod to identify protein sequences that fold into a known three-dimensional structureUNIV CALIFORNIA·Filed 1994·Granted Jul 25, 1995·94 cites·26 claims
- 0985US7459439B2Granulysin peptides and methods of use thereofUNIV CALIFORNIA·Filed 2005·Granted Dec 2, 2008·6 cites·2 claims
- 1085US6772069B1Determining protein function and interaction from genome analysisUNIV CALIFORNIA LOS ANGELES·Filed 2000·Granted Aug 3, 2004·15 cites·23 claims
- 1184US7314916B2Methods and materials for characterizing and modulating interaction between heregulin and HER3UNIV CALIFORNIA·Filed 2006·Granted Jan 1, 2008·7 cites·4 claims
- 1282US10815271B2Structure-based peptide inhibitors of alpha-synuclein aggregationUNIV CALIFORNIA·Filed 2017·Granted Oct 27, 2020·2 cites·19 claims
- 1378US8754034B2Structure-based design of peptide inhibitors of amyloid fibrillationEISENBERG DAVID S·Filed 2010·Granted Jun 17, 2014·5 cites·14 claims
- 1469US2023069905A1Structure-based peptide inhibitors of alpha-synuclein aggregationUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1566US9873718B2Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeuticsUNIV CALIFORNIA·Filed 2014·Granted Jan 23, 2018·1 cites·16 claims
- 1664US11390646B2Structure-based peptide inhibitors of α-synuclein aggregationUNIV CALIFORNIA·Filed 2020·Granted Jul 19, 2022·0 cites·20 claims
- 1761US9463195B2Dissolution of amyloid fibrils by flavonoids and other compoundsEISENBERG DAVID S·Filed 2007·Granted Oct 11, 2016·1 cites·16 claims
- 1859US2005209837A1Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling or related proteinsBEAMER LESA J·Filed 2004·Application pending·0 cites
- 1951US10400010B2Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeuticsUNIV CALIFORNIA·Filed 2018·Granted Sep 3, 2019·0 cites·30 claims
- 2051US2004014153A1Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteinsFiled 2002·Application pending·0 cites
- 2145US10934332B2Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segmentUNIV CALIFORNIA·Filed 2018·Granted Mar 2, 2021·0 cites·10 claims
- 2244US6512981B1Protein fold recognition using sequence-derived predictionsUNIV CALIFORNIA·Filed 1998·Granted Jan 28, 2003·11 cites·27 claims
- 2342US2023226016A1Agents and methods for treating tauopathiesTHE REGENTS OF UNIV OF CALIFORNIA·Filed 2021·Application pending·0 cites
- 2442US2015307573A1Cylindrins as etiologic agents of amyloid diseasesUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 2537US2014154180A1Pharmacophores for Amyloid Fibers Involved in Alzheimer's DiseaseEISENBERG DAVID S·Filed 2012·Application pending·0 cites
- 2633US11028128B2Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segmentsUNIV CALIFORNIA·Filed 2017·Granted Jun 8, 2021·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when David S. Eisenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →